Globus Medical GMED
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$22.62M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 38.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.07% to 7.04% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Swedbank Robur Fonder AB | Mutual Fund | 2026/Q3 | +2,360,480 | 2.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +1,860,564 | 2.6% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,093,085 | 1.7% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,093,085 | 1.7% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +638,132 | 2.3% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +225,534 | 1.4% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +208,000 | 0.3% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +194,296 | 0.2% |
| Kayne Anderson Rudnick Investment Management, LLC | Mutual Fund | 2026/Q3 | +4,279,730 | 3.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +1,554,990 | 1.2% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +1,143,641 | 1.2% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +803,716 | 1.3% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q3 | +672,003 | 0.9% |
| Wells Fargo & Company | Public Company | 2026/Q3 | +668,668 | 0.7% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +629,512 | 1.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | James Tobin | Independent Director | Derivative Exercise and Sale | -41,666 | $75.68 | – |
| 3 Nov 2026 | Ann Rhoads | Independent Director | Automatic Disposition | -5,000 | $85.00 | 35,384 |
| 14 Sep 2026 | James Tobin | Independent Director | Derivative Exercise and Sale | -30,000 | $74.58 | – |
| 17 Aug 2026 | Stephen Zarrilli | Independent Director | Derivative Exercise and Sale | -25,000 | $87.04 | – |
| 26 Jul 2026 | David Davidar | Independent Director | Other Disposition | -2,500 | – | 673,642 |
| 4 Jun 2026 | David Davidar | Independent Director | Derivative Exercise and Sale | -25,000 | $80.76 | 676,142 |
| 3 Jun 2026 | Ann Rhoads | Independent Director | Derivative Exercise and Retained | +25,000 | $26.27 | 40,384 |
| 13 Apr 2026 | John DeFord | Former Independent Director | Intent to Sell (Form 144) | -30,000 | $93.10 | – |
| 24 Feb 2026 | Kelly Huller | General Counsel | Derivative Exercise and Sale | -20,000 | $94.50 | – |
| 11 Feb 2026 | Kelly Huller | General Counsel | Derivative Exercise and Sale | -10,000 | $87.67 | – |
| 20 Jan 2026 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | John DeFord | Former Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Stephen Zarrilli | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | James Tobin | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | David Paul | Co-Founder & Executive Chairperson | Other Derivative Acquisition | +100,000 | $94.15 | 100,000 |
| 20 Jan 2026 | Daniel Wolterman | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Robert Douglas | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | David Davidar | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Leslie Norwalk | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Daniel Lemaitre | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,455,426 | 7.0% | 8.1 |
| 15 Oct 2026 | 8,189,831 | 6.1% | 5.5 |
| 30 Sep 2026 | 8,437,114 | 6.3% | 5.1 |
| 15 Sep 2026 | 6,767,512 | 5.0% | 4.6 |
| 31 Aug 2026 | 6,620,718 | 4.9% | 6.5 |
| 14 Aug 2026 | 6,802,529 | 5.1% | 4.0 |
No comments yet — be the first to weigh in on GMED.
Sign in to join the discussion.